Eosinophil differentiating activity in sera of patients with AIDS under recombinant IL-2 substitution
暂无分享,去创建一个
[1] M. Ernst,et al. Effects of systemicin vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC) , 1986, Journal of Clinical Immunology.
[2] M. Strath,et al. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures , 1985, The Journal of experimental medicine.
[3] M. Vadas,et al. Regulation of human granulocyte function by products derived from murine tumors. , 1985, Experimental hematology.
[4] K. Welte,et al. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells. , 1985, Journal of immunology.
[5] S. Rosenberg,et al. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. , 1985, Journal of immunology.
[6] R. Mertelsmann,et al. Human Interleukin-2 , 1984, Clinics in Immunology and Allergy.
[7] A. Chang,et al. The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma. , 1984, Journal of immunology.
[8] S. Rosenberg,et al. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2 , 1984, The Journal of experimental medicine.
[9] B. Rouse,et al. Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. , 1984, Science.
[10] B. Czarnetzki,et al. The effect of eosinophil chemotactic factors on in vitro eosinopoiesis in the guinea pig , 1983, Blut.
[11] B. Safai,et al. Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and itsin vitro correction by interleukin 2 , 1983, Journal of Clinical Immunology.
[12] J. Goedert,et al. Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. , 1982, The Journal of infectious diseases.
[13] S. Rosenberg,et al. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. , 1981, Cancer research.
[14] R. Gallo,et al. RC Gallo lymphocytes Human T-lymphocyte growth factor : regulation of growth and function of T , 1981 .
[15] J. Goldberg,et al. Myeloid differentiation of human blood mononuclear cells in liquid culture. , 1981, Blood.
[16] D. Bass,et al. Stimulation of eosinophil production in vitro by eosinophilopoietin and spleen-cell-derived eosinophil growth-stimulating factor , 1980 .
[17] G. Johnson,et al. Detection of a new type of mouse eosinophil colony by Luxol-fast-blue staining. , 1980, Experimental hematology.
[18] T. Cockerell. THE NEEDS OF SCIENTIFIC MEN. , 1905, Science.
[19] M. Dietrich,et al. Preliminary clinical observations with recombinant interleukin-2 in patients with AIDS or LAS , 2004, Blut.
[20] J. Curran,et al. Epidemiology of the acquired immunodeficiency syndrome , 1985 .
[21] P. Volberding,et al. Interferon and interleukin-2 therapy of Kaposi's sarcoma. , 1985, Advances in experimental medicine and biology.
[22] J. Curran,et al. Epidemiology of the acquired immunodeficiency syndrome (AIDS). , 1985, Epidemiologic reviews.
[23] D. Bass,et al. Stimulation of eosinophil production in vitro by eosinophilopoietin and spleen-cell-derived eosinophil growth-stimulating factor. , 1980, Blood.